Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis

被引:9
|
作者
Yazihan, Naksidil Torun [1 ]
Yetkin, Sinan [2 ]
机构
[1] Cankaya Univ, Dept Psychol, Ankara, Turkey
[2] Hlth Sci Univ, Dept Psychiat, Ankara, Turkey
来源
JOURNAL OF CLINICAL SLEEP MEDICINE | 2020年 / 16卷 / 12期
关键词
first-episode psychosis; sleep; sleep architecture; sleep spindle; neuropsychology; schizophrenia; SLOW-WAVE SLEEP; 1ST EPISODE PSYCHOSIS; EYE-MOVEMENT SLEEP; NON-REM SLEEP; SCHIZOPHRENIA-PATIENTS; NEGATIVE SYMPTOMS; ELECTROENCEPHALOGRAPHIC SLEEP; DEFICITS; ABNORMALITIES; PERFORMANCE;
D O I
10.5664/jcsm.8776
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Objectives: Various lines of clinical findings have suggested abnormalities in macro- or microstructural parameters of sleep in patients with schizophrenia. Meanwhile findings are inconclusive due to some confounding factors, such as the heterogeneity of the disorder, drug regimen, and duration of the illness. There are a few studies in the literature that have been conducted on drug-free patients with first-episode psychosis (FEP). Based on this knowledge, we aimed to explore sleep characteristics, sleep spindles, and neuropsychological profiles of the drug-naive patients with FEP. Methods: The study sample consisted of 21 drug-naive patients with FEP and 21 healthy participants. Polysomnography recordings were conducted for 2 subsequent nights. A neuropsychological test battery was administered for assessing cognitive functions. The Positive and Negative Syndrome Scale was applied to measure symptom severity of the patients. Spindle detection was performed visually. Results: According to the results of the study, the patient group's percentage of stage N2 sleep and sleep efficiency index was lower than in the control group. Among sleep spindle parameters, spindle density was found to be reduced in the patient group. The results of neuropsychological tests measuring executive functions, learning, and memory support the idea that there is a global cognitive deterioration from the early course of the disorder. In the psychotic group, negative symptoms were negatively correlated with verbal memory, learning, verbal fluency, and semantic organization. We found that the percentage of stage N3 sleep decreased while negative symptom severity increased. In addition, the percentage of stage N1 sleep increased as negative symptom severity increased. Reduction in stage N3 sleep was associated with an impairment in learning, verbal fluency, and response inhibition. The sleep spindle density and cognitive functions did not show any associations. Conclusions: Taken together, these findings suggest that patients with FEP show global cognitive impairment (except for attention and processing speed), which is associated with changes in sleep architecture and higher score in a scale assessing negative symptoms. We conclude that cognitive function and spindle parameters differ nonlinearly among patients with FEP.
引用
收藏
页码:2079 / 2087
页数:9
相关论文
共 50 条
  • [31] Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients
    Delgado-Alvarado, Manuel
    Tordesillas-Gutierrez, Diana
    Ayesa-Arriola, Rosa
    Canal, Manuel
    Ortiz-Garcia de la Foz, Victor
    Labad, Javier
    Crespo-Facorro, Benedicto
    ARCHIVES OF WOMENS MENTAL HEALTH, 2019, 22 (03) : 367 - 373
  • [32] Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia
    Spelman, L. M.
    Walsh, P. I.
    Sharifi, N.
    Collins, P.
    Thakore, J. H.
    DIABETIC MEDICINE, 2007, 24 (05) : 481 - 485
  • [33] State-dependent microstructural white matter changes in drug-naive patients with first-episode psychosis
    Serpa, M. H.
    Doshi, J.
    Erus, G.
    Chaim-Avancini, T. M.
    Cavallet, M.
    de Bilt, M. T. van
    Sallet, P. C.
    Gattaz, W. F.
    Davatzikos, C.
    Busatto, G. F.
    Zanetti, M. V.
    PSYCHOLOGICAL MEDICINE, 2017, 47 (15) : 2613 - 2627
  • [34] Microglial activation in first-episode and drug-naive schizophrenia
    Iwata, Y.
    Suzuki, K.
    Mori, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 62 - 62
  • [35] Hyperprolactinemia in drug-naive first-episode patients: data from EUFEST
    Riecher-Roessler, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S126 - S126
  • [36] Evaluation of Dopamine Transporter in First-episode Drug-naive Psychotic Patients
    Reis, Marilia A.
    Gadelha, Ary
    Noto, Cristiano
    Higuchi, Cinthia H.
    Batista, Ilza R.
    Calzavara, Mariana B.
    Abilio, Vanessa C.
    Castiglioni, Mario L. V.
    Belangero, Sintia I.
    Cordeiro, Quirino
    Bressan, Rodrigo A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 249S - 250S
  • [37] Aspects of metabolic changes in first-episode drug-naive schizophrenic patients
    Uzbekov, Marat G.
    Misionzhnik, Eduard
    Gurovich, Isaak
    Shmukler, Alexander
    Moskvitina, Tatjana
    ACTA NEUROPSYCHIATRICA, 2013, 25 (05): : 268 - 274
  • [38] Imaging dopamine transmission in drug-naive, first-episode patients with schizophrenia
    Martinez, D
    Kegeles, L
    Printz, D
    Gil, R
    Zea-Ponce, Y
    Mann, J
    Gorman, J
    Laruelle, M
    Abi-Dargham, A
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 243 - 244
  • [39] Cerebellar Functional Dysconnectivity in Drug-Naive Patients With First-Episode Schizophrenia
    Cao, Hengyi
    Wei, Xia
    Zhang, Wenjing
    Xiao, Yuan
    Zeng, Jiaxin
    Sweeney, John A.
    Gong, Qiyong
    Lui, Su
    SCHIZOPHRENIA BULLETIN, 2023, 49 (02) : 417 - 427
  • [40] Examining neuropsychological function in drug-naive first-episode schizophrenic patients
    Fagerlund, B
    Mackeprang, T
    Gade, A
    Hemmingsen, R
    Glenthoj, B
    NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 : 17 - 17